The use of serum zinc to prostate-specific antigen ratio as a biomarker in the prediction of prostate biopsy outcomes

Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance

(2016) Matteo Ferro et al.   Oncotarget

Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging

(2015) Ottavio de Cobelli et al.   PLoS One

Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance

(2015) Ottavio de Cobelli et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Biomarkers in prostate cancer: new era and prospective

(2014) Amrallah A. Mohammed   MEDICAL ONCOLOGY

Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with “gray” prostate-specific antigen levels at first biopsy: systematic review and meta-analysis

(2014) Dario Bruzzese et al.   Translational Research

Serum zinc and prostate cancer risk in a nested case-control study: The multiethnic cohort

(2012) Song-Yi Park et al.   PROSTATE

Beyond PSA: The Next Generation of Prostate Cancer Biomarkers

(2012) J. R. Prensner et al.   Science Translational Medicine

Zinc in Specialized Secretory Tissues: Roles in the Pancreas, Prostate, and Mammary Gland

(2012) Shannon L. Kelleher et al.   Advances in Nutrition

The Contemporary Concept of Significant Versus Insignificant Prostate Cancer

(2011) Guillaume Ploussard et al.   EUROPEAN UROLOGY

Youden Index and Optimal Cut-Point Estimated from Observations Affected by a Lower Limit of Detection

(2008) Marcus D. Ruopp et al.   BIOMETRICAL JOURNAL